News

Revascularization Underused in Cardiogenic Shock


 

Both percutaneous coronary interventions and coronary artery bypass grafting are seriously underused in patients with MI complicated by cardiogenic shock, according to a nationwide survey.

The American College of Cardiology and the American Heart Association revised their guidelines in 1999, elevating early mechanical intervention for cardiogenic shock to a class I recommendation for patients younger than 75 with an ST-elevation left bundle-branch block acute MI. However, a national database that has tracked practice patterns and MI outcomes since 1990 showed that physicians have been slow to comply with this change and had only marginally increased the use of PCI and CABG in this patient group by early 2004, the most recent year for which data were available, said Anvar Babaev, M.D., of New York University, New York, and colleagues (JAMA 2005;294:448–54).

The database included nearly 300,000 MI patients treated at 775 hospitals with revascularization capability. Of these, more than 25,000 (8.6%) had cardiogenic shock. Mortality clearly decreased with increasing use of revascularization, illustrating the benefit of early mechanical intervention. But physicians may still be reluctant to try these interventions in high-risk patients, the investigators said.

Recommended Reading

Missed Ischemia Equals Poorer Care, Survival
MDedge Cardiology
Serum Melatonin: New MI Outcome Predictor?
MDedge Cardiology
Quality Initiatives Shorten Mayo's Door-to-Balloon Time
MDedge Cardiology
Better GI Bleeding Prophylaxis Needed After Stenting
MDedge Cardiology
New Guidelines Tackle Postsurgical Atrial Fib
MDedge Cardiology
Amiodarone Cuts Postop Atrial Fib
MDedge Cardiology
B Vitamin Therapy Doesn't Trim MI, Stroke Risks : No patient subgroup gained from the therapy, and those with high baseline homocysteine fared worse.
MDedge Cardiology
Device May Improve Outcomes of In-Hospital Cardiac Arrest
MDedge Cardiology
Late Thrombosis Below 1% With Eluting Stents
MDedge Cardiology
Shot May Be Alternative to Drug-Eluting Stents
MDedge Cardiology